Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
about
The safety and efficacy of antithrombotic therapy in patients undergoing cardiac rhythm device implantation: a meta-analysisMeta-analysis of bleeding complications associated with cardiac rhythm device implantationImpact of body mass index on the development of pocket hematoma: A retrospective study in Chinese people.Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data RegistryPerioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.Anticoagulant use, the prevalence of bridging, and relation to length of stay among hospitalized patients with non-valvular atrial fibrillation.Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients.Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices.Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy.Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.Pocket Hematoma: A Call for Definition.Managing anticoagulation in patients receiving implantable cardiac devices.Analysis of Complications in Outpatient ICD Surgery On or Off Warfarin Anticoagulation.Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.Incidence of pocket hematoma after electrophysiological device placement: dual antiplatelet therapy versus low-molecular-weight heparin regimen.Safety of anticoagulation with uninterrupted warfarin vs. interrupted dabigatran in patients requiring an implantable cardiac device.Treatment with novel oral anticoagulants in a real-world cohort of patients undergoing cardiac rhythm device implantations.Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.Uninterrupted warfarin therapy for the implantation of cardiac rhythm devices.Managing anticoagulation in patients receiving implantable cardiac devices.Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk.Remote follow-up of pacemakers in a selected population of debilitated elderly patients.Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Soc
P2860
Q26829026-66A0093C-0251-4A68-B1D8-FCCF2C6DED6BQ27025569-FD6867E0-D414-4723-9FE7-527C6A7B606AQ34260440-E13072A9-070F-4A5B-8F2B-7C9C884B9567Q34547178-E9476E92-AEE0-47E2-A031-E1B73F108F8EQ35262940-05FEC572-CA6C-4D6F-B593-8BC822A77B39Q37020949-018D7CCE-8C5A-45A5-A99D-9A1818500F3FQ37496889-3B8DA252-91F0-4165-949E-28C302218B3CQ37677988-7EAB672F-725C-489B-A022-E513F84A19E3Q37868373-C559BBE4-8A9A-4C79-AAC3-025F100086A4Q37880138-7E112177-C293-4651-A14F-C5E333D84FA2Q37961826-64679BAA-44D9-413E-82DC-3E6613979CB5Q38302583-B112BBD4-27A4-49C6-9B59-AF6612B2383EQ38364982-F5FA1B12-0C36-41E8-805D-04054E20C3F6Q38479890-279C9F77-E57C-4C42-B45D-4C6C1C8F16EBQ38552586-87F2BEB6-38A2-4480-B257-2B079440AF28Q39485194-F13D0A05-2CE1-4C77-9A09-AF8870644AF1Q40069714-B30A553B-D1B3-4A1E-9623-B718804F945BQ41717562-D4450039-02B1-417A-AFA6-30F24A4AD454Q42013753-374CFBC5-6BA3-4C9B-BA08-66FC8FBAA1CEQ44581048-4D53F5FC-CE0C-4E72-8300-F951194E9513Q44644201-34948957-D647-4888-A1DD-B24FD39982D7Q45921775-302A4FE3-D7F2-4636-9D9A-75E4A085C5D1Q47262760-8EFDC296-7316-4F8E-BCF9-B36E732F28EDQ51008142-78A79A11-1944-4B6D-8EE6-50D70B5E7EE2Q51197429-018B7309-A36B-464D-AEE4-F25D51FBB2BCQ57626457-4E6E6D29-7760-44EC-BB77-EA42C4285DFC
P2860
Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preparation for pacemaker or i ...... A prospective randomized trial
@en
Preparation for pacemaker or i ...... prospective randomized trial.
@nl
type
label
Preparation for pacemaker or i ...... A prospective randomized trial
@en
Preparation for pacemaker or i ...... prospective randomized trial.
@nl
prefLabel
Preparation for pacemaker or i ...... A prospective randomized trial
@en
Preparation for pacemaker or i ...... prospective randomized trial.
@nl
P2093
P2860
P50
P921
P356
P1476
Preparation for pacemaker or i ...... A prospective randomized trial
@en
P2093
Begoña Benito
David Tamborero
Joan Monteagudo
Jose M Tolosana
Magda Heras
Paola Berne
P2860
P304
P356
10.1093/EURHEARTJ/EHP194
P577
2009-05-31T00:00:00Z